bioRxiv Science⌕ Search

bioRxiv · 10.1101/2022.02.18.480983

Benchmarking Polygenic Risk Score Model Assumptions: towards more accurate risk assessment

Abstract

Polygenic risk scores represent an individuals genetic susceptibility to a phenotype. Like with any models, statistical models commonly employed to fit polygenic risk scores and assess their accuracy contain several assumptions. The effects of these assumptions on models of polygenic risk score have not been thoroughly assessed. We assessed 26 variations of the traditional polygenic risk score model, each of which mitigate assumptions in one of five facets of disease modelling: representation of age (6 variations), censorship (3 variations), competing risks (7 variations), formation of disease labels (6 variations), and selection of covariates (4 variations). With data from the UK Biobank, each model variation included age, sex, and a polygenic risk score derived from the PGS Catalog. Each of the 26 model variations were fitted to predict 18 diseases. Compared to the plain model that contained all five facets of assumptions, the model variations often fit the data better and generated predictions that largely differed from the predictions of the plain model. The statistic Roystons R2 measured a models goodness of fit, and thereby determined if the model was an enhancement upon the plain model. For 15 of the 26 model variations Roystons R2 was greater than that of the plain model for >50% of diseases. Reclassification rates, defined as the fraction of individuals in the top five percentiles of the plain models predictions who are not in the top five percentiles of a model variations predictions, was used to determine if the variation led to significantly different predictions. For 20 of the 26 model variations the median reclassification rate calculated across the 18 diseases was greater than 10%. Comparisons of accuracy statistics further illustrated how much each model variations predictions differed from the plain models predictions. Models containing polygenic risk scores appear to be significantly affected by many common modelling assumptions. Therefore, future investigations should consider taking some action to mitigate modelling assumptions. Author SummaryAn individuals genetics can increase their risk of experiencing a disease. The exact magnitude of the increased risk is estimated within a statistical model. The traditional model type employed in this process is relatively plain and contains several assumptions. The predicted risk estimates from this plain model may be unnecessarily inaccurate. To test this possibility, we searched the literature for model variations that reduce the assumptions of the plain model, ultimately creating 26 distinct model variations that may improve upon the plain model. Each model variation was fit with data from the UK Biobank to predict 18 diseases. We found that 15 of the 26 models variations fit the data better than the plain model for a majority of diseases. Goodness of fit was measured with Roystons R2 statistic. Further calculations found that the predictions of the model variations were often significantly more or less accurate than the predictions of the plain model. We believe these results indicate that future investigations of polygenic risk scores should not employ the plain model, as unreliable risk predictions will likely result.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kulm, S., Mezey, J., Elemento, O.. 2022-02-18. Benchmarking Polygenic Risk Score Model Assumptions: towards more accurate risk assessment. https://doi.org/10.1101/2022.02.18.480983

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

SPACE-Tag Enables High-Throughput Spatial Chromatin Profiling With CUT&Tag

Spatial epigenomics maps chromatin states within intact tissues, yet current methods remain limited by accessibility and scale. We developed SPACE-Tag, a spatial CUT&Tag framework that converts epigenetic marks-associated DNA into polyadenylated RNA through T7 based linear amplification, enabling direct integration with standard spatial transcriptomic workflows. Applied to the mouse brain, SPACETag resolved activating and repressive chromatin landscapes, recovered region-specific gene regulatory programs across anatomical domains, and showed strong correlation with existing bulk and single cell reference data. We generated an integrated multimodal atlas of the aging mouse brain, profiling five histone modifications and the transcriptome in parallel across the adult lifespan to establish the largest spatial multimodal dataset to date. This analysis uncovered sharp regional divergence with aging in the brain: fiber tracts showed widespread transcriptional downregulation, often without nearby chromatin state transitions, whereas the isocortex showed coordinated chromatin transcriptome changes, including an H3K4me1 peak module that increased with age, was enriched at super-enhancers and linked to upregulation of neuronal plasticity regulators. These findings highlight the power of multimodal and high throughput spatial genomics in uncovering the divergent regulatory logic that governs tissue-specific vulnerability and resilience in the aging brain.

genomics↗

Long-read DNA sequencing reveals global hypomethylation and focal hypermethylation in SDHx-deficient pheochromocytoma and paraganglioma

Pheochromocytomas and paragangliomas (PPGL) are highly heritable neuroendocrine tumors of the autonomic ganglia. Genomic DNA in most cancer cells is hypomethylated. However, DNA in PPGLs secondary to mutations in succinate dehydrogenase complex (SDHx) genes is reportedly hypermethylated due to succinate-mediated inhibition of DNA demethylases. We used nanopore long-read sequencing to characterize the methylome of tumor and white blood cell DNA from SDHx and non-SDHx PPGL patients, alongside normal adrenal medulla. We find that both SDHx and non-SDHx PPGLs are globally hypomethylated, particularly at centromeres. In normal adrenal medulla, CpG islands marked by H3K4 methylation are hypomethylated, whereas CpG islands lacking H3K4 methylation are hypermethylated. In SDHx-related PPGL, some H3K4me-marked CpG islands are hypermethylated, but most are not. We propose that DNA methylation in SDHx-related PPGL reflects the global hypomethylation generally observed in tumors, partly offset by succinate-mediated inhibition of TET DNA demethylases. Opposing effects of succinate may alter the balance between DNA methylation (indirect inhibition of the DNMT3A/B DNA methylases via inhibition of H3K4me demethylases) and DNA demethylation (inhibition of TET DNA demethylases) at active CpG islands.

genomics↗

High piRNA abundance is a hallmark of evolutionarily persistent piRNA-producing loci.

PIWI-interacting RNAs (piRNAs) silence transposons in the germline, and the loci that produce them diverge rapidly between species. Yet, some loci retain both their genomic location and their piRNA production across large evolutionary distances, and the basis for this conservation is unclear. To identify the features that distinguish these persistent loci, we compared piRNA production at orthologous loci in three closely related mouse species, contrasting loci that produce piRNAs in all three species with those that do so in only one. Transposon content and UTR features, often linked to piRNA production, did not distinguish the two groups. Transcription extending beyond gene ends (readthrough) was more frequent at conserved loci, but did not explain conservation once the amount of piRNAs produced was taken into account. Instead, we found that the conserved loci are those that produce the most piRNAs. The same association holds true in human and two other primate species. We speculate that most piRNAs expressed in testis are tolerated molecular noise, and that only the highly expressed minority are likely to be functional.

genomics↗